Ian B Ross1, Gurmeet S Dhillon. 1. Department of Neurosurgery, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Abstract
BACKGROUND AND PURPOSE: Recent evidence suggests that endovascular treatment of acutely ruptured aneurysms is equivalent, if not superior, to surgical treatment. Not all patients who undergo endovascular treatment do well, however. We have identified ventriculostomy-related hemorrhage to be a potential source of morbidity and mortality. METHODS: Prospectively gathered data on patients (n = 51) admitted to a hospital for the endovascular treatment of acutely ruptured aneurysms during a 2.5-year period was analyzed. RESULTS: Twenty-four patients had drains inserted, and three suffered symptomatic ventriculostomy-related cerebral hemorrhages. Two of the three patients were being treated with heparin, one of whom also received clopidogrel, and the third was being treated with low molecular weight heparin at the time. The latter had a normal platelet count, prothrombin time, and activated partial thromboplastin time. All cerebral hemorrhages were deemed to have occurred as a result of drain manipulation. CONCLUSION: The risk of hemorrhage must be considered when using anticoagulation and antiplatelet therapy in patients requiring ventriculostomy. Interventionalists must not only work closely with neurosurgeons when it is anticipated that a ventriculostomy may be needed but also ensure that there is good communication with the neurosurgical team during the postprocedural period.
BACKGROUND AND PURPOSE: Recent evidence suggests that endovascular treatment of acutely ruptured aneurysms is equivalent, if not superior, to surgical treatment. Not all patients who undergo endovascular treatment do well, however. We have identified ventriculostomy-related hemorrhage to be a potential source of morbidity and mortality. METHODS: Prospectively gathered data on patients (n = 51) admitted to a hospital for the endovascular treatment of acutely ruptured aneurysms during a 2.5-year period was analyzed. RESULTS: Twenty-four patients had drains inserted, and three suffered symptomatic ventriculostomy-related cerebral hemorrhages. Two of the three patients were being treated with heparin, one of whom also received clopidogrel, and the third was being treated with low molecular weight heparin at the time. The latter had a normal platelet count, prothrombin time, and activated partial thromboplastin time. All cerebral hemorrhages were deemed to have occurred as a result of drain manipulation. CONCLUSION: The risk of hemorrhage must be considered when using anticoagulation and antiplatelet therapy in patients requiring ventriculostomy. Interventionalists must not only work closely with neurosurgeons when it is anticipated that a ventriculostomy may be needed but also ensure that there is good communication with the neurosurgical team during the postprocedural period.
Authors: Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman Journal: Lancet Date: 2002-10-26 Impact factor: 79.321
Authors: R L Macdonald; C Amidei; G Lin; I Munshi; J Baron; B K Weir; F Brown; R K Erickson; J Hekmatpanah Journal: Neurosurgery Date: 1999-08 Impact factor: 4.654
Authors: Michael J Workman; Harry J Cloft; Frank C Tong; Jacques E Dion; Mary E Jensen; William F Marx; David F Kallmes Journal: AJNR Am J Neuroradiol Date: 2002-10 Impact factor: 3.825
Authors: G Agnelli; F Piovella; P Buoncristiani; P Severi; M Pini; A D'Angelo; C Beltrametti; M Damiani; G C Andrioli; R Pugliese; A Iorio; G Brambilla Journal: N Engl J Med Date: 1998-07-09 Impact factor: 91.245
Authors: Joseph Zachariah; Kendall A Snyder; Christopher S Graffeo; Deependra R Khanal; Giuseppe Lanzino; Eelco F M Wijdicks; Alejandro A Rabinstein Journal: Neurocrit Care Date: 2016-10 Impact factor: 3.210
Authors: Jack M Leschke; Andrew Lozen; Mayank Kaushal; Akinwunmi Oni-Orisan; Mazen Noufal; Osama Zaidat; Glen A Pollock; Wade M Mueller Journal: Neurocrit Care Date: 2017-08 Impact factor: 3.210
Authors: Pankajavalli Ramakrishnan; Albert J Yoo; James D Rabinov; Christopher S Ogilvy; Joshua A Hirsch; Raul G Nogueira Journal: Interv Neurol Date: 2013-10
Authors: DeWitte T Cross; Christopher J Moran; Colin P Derdeyn; Avi Mazumdar; Dennis Rivet; Michael M Chicoine Journal: AJNR Am J Neuroradiol Date: 2005 Nov-Dec Impact factor: 3.825
Authors: B Jankowitz; A J Thomas; N Vora; R Gupta; E Levy; J Yamamoto; A Kassam; Y Gologorsky; N Panapitiya; E Sandhu; E Crago; A Hricik; K Lee; M Gallek; T Jovin; M Horowitz Journal: Interv Neuroradiol Date: 2009-01-05 Impact factor: 1.610